Berman David M's Form 4 filing
Immunocore Holdings plc (IMCR) · filed Mar 1, 2024
- Accession no.
- 0001415889-24-006079
- Filed
- Mar 1, 2024
- Trade date
- Feb 28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Berman David MCIK 0001955244 | Officer (HEAD OF R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Ordinary Shares | MOption exerciseAcquired | +36,509 | $17.46 | +$637,447.14 | 36,509 | Direct | |
| Feb 28, 2024 | Ordinary Shares | SSaleDisposed | −16,900 | $67.61 | −$1,142,609 | 19,609 | Direct | |
| Feb 28, 2024 | Ordinary Shares | SSaleDisposed | −7,472 | $68.84 | −$514,372.48 | 12,137 | Direct | |
| Feb 28, 2024 | Ordinary Shares | SSaleDisposed | −10,937 | $69.73 | −$762,637.01 | 1,200 | Direct | |
| Feb 28, 2024 | Ordinary Shares | SSaleDisposed | −1,200 | $70.45 | −$84,540 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Ordinary Shares | MOption exerciseDisposed | −36,509 | $0.00 | $0 | 271,790 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.